facebook
TradedTraded
    Home
    Deals
    Newsletter
    Articles
    PropTech


Messages

Go Pro
+ Submit+ Submit
All Deals
March 12, 2025 - Deals

Junction Secures $18 Million In Series A Funding Led By Creandum With Participation From Y Combinator

No image placeholder
Junction, a New York-based API platform for integrating health wearables and lab services, has raised $18M in Series A funding led by Creandum, with participation from Y Combinator, Point Nine, and Amino Collective. Founded by CEO Maitham Dib, a former Babylon Health engineer, Junction connects over 500 medical devices and facilitates lab testing across all 50 U.S. states. With 2M+ devices connected and 1M lab tests projected this year, the platform aims to streamline healthcare data integration, improving accessibility and efficiency for companies like Found, Parsley Health, and Evidation. INVESTORS: Creandum, Y Combinator, Point Nine & Amino Collective ROUND: Series A AMOUNT: $18,000,000 HQ: #NewYork #NY #NewYorkCity #NYC #VentureCapital #Junction #Creandum #YCombinator #PointNine #AminoCollective #TradedVC

Property Image
Jasper Therapeutics Acquires Kira Pharmaceuticals For $132 Million With Investment From Affinity Asset Advisors And Ikarian CapitalJasper Therapeutics has completed its all-stock acquisition of Kira Pharmaceuticals and secured approximately $132 million in new capital through a private placement, creating a combined immunology-focused biotech company with a three-asset pipeline. The financing was co-led by Affinity Asset Advisors and Ikarian Capital, with participation from several institutional investors, and is expected to support operations through the second half of 2028. The merged company will advance programs including KP-104, briquilimab, and KP-701, while Kira has also out-licensed two additional assets to Mirador Therapeutics in a deal that includes upfront, milestone, and royalty payments. Jasper CEO Jeet Mahal will continue to lead the combined company, which will remain listed on Nasdaq under the ticker JSPR. SALE PRICE: $132,000,000 HQ: Redwood City, California #VentureCapital #JasperTherapeutics #KiraPharmaceuticals #TradedVC
Property Image
Runta Raises $20 Million Seed Round Led By A16z For AI Agent InfrastructureRunta, a San Francisco Bay Area startup building the execution layer for AI agents, has raised a $20 million seed round led by a16z. The company’s platform helps organizations control what AI agents can do while they run by limiting access, capping spending, and maintaining records of agent actions. Founded by Guanlan Dai, Runta aims to provide the infrastructure and guardrails needed to safely deploy and manage autonomous AI agents at scale. FOUNDER: Guanlan Dai INVESTOR: a16z ROUND: Seed AMOUNT: $20,000,000 HQ: San Francisco Bay Area, California #VentureCapital #Runta #TradedPartner #GuanlanDai #TradedVC